Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, Open-label Study of Oral S241656 (BDTX-4933) as Monotherapy and in Combination With Other Anti-Cancer Therapies in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05786924
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:05.447778+00:00
Published At
2026-04-21T00:00:00+00:00
Record Updated At
2026-04-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-small Cell Lung Cancer", "Histiocytic Neoplasm", "Histiocytosis", "BRAF Gene Mutation", "BRAF V600E", "BRAF V600 Mutation", "BRAF Mutation-Related Tumors", "BRAF", "Metastatic Lung Non-Small Cell Carcinoma", "Metastatic Lung Cancer", "Recurrent Lung Cancer", "Recurrent Lung Non-Small Cell Carcinoma", "NSCLC", "Solid Tumor", "Solid Carcinoma", "KRAS G12D", "KRAS G12V", "KRAS Mutation-Related Tumors", "NRAS Gene Mutation", "Thyroid Cancer", "Thyroid Carcinoma", "Colorectal Cancer", "Colorectal Carcinoma", "Recurrent Histiocytic and Dendritic Cell Neoplasm", "Brain Metastases", "Recurrent NSCLC", "KRAS G13C", "Acquired Resistance to KRAS G12C Inhibitor", "KRAS G12A", "KRAS G12F", "KRAS G12R", "KRAS G13D"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-21"
protocolSection.identificationModule.nctId
"NCT05786924"
protocolSection.identificationModule.officialTitle
"A Phase 1/2, Open-label Study of Oral S241656 (BDTX-4933) as Monotherapy and in Combination With Other Anti-Cancer Therapies in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • Histiocytic Neoplasm (protocolSection.conditionsModule.conditions)
  • Histiocytosis (protocolSection.conditionsModule.conditions)
  • BRAF Gene Mutation (protocolSection.conditionsModule.conditions)
  • BRAF V600E (protocolSection.conditionsModule.conditions)
  • BRAF V600 Mutation (protocolSection.conditionsModule.conditions)
  • BRAF Mutation-Related Tumors (protocolSection.conditionsModule.conditions)
  • BRAF (protocolSection.conditionsModule.conditions)
  • Metastatic Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Lung Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Lung Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • NSCLC (protocolSection.conditionsModule.conditions)
  • Solid Tumor (protocolSection.conditionsModule.conditions)
  • Solid Carcinoma (protocolSection.conditionsModule.conditions)
  • KRAS G12D (protocolSection.conditionsModule.conditions)
  • KRAS G12V (protocolSection.conditionsModule.conditions)
  • KRAS Mutation-Related Tumors (protocolSection.conditionsModule.conditions)
  • NRAS Gene Mutation (protocolSection.conditionsModule.conditions)
  • Thyroid Cancer (protocolSection.conditionsModule.conditions)
  • Thyroid Carcinoma (protocolSection.conditionsModule.conditions)
  • Colorectal Cancer (protocolSection.conditionsModule.conditions)
  • Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Histiocytic and Dendritic Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Brain Metastases (protocolSection.conditionsModule.conditions)
  • Recurrent NSCLC (protocolSection.conditionsModule.conditions)
  • KRAS G13C (protocolSection.conditionsModule.conditions)
  • Acquired Resistance to KRAS G12C Inhibitor (protocolSection.conditionsModule.conditions)
  • KRAS G12A (protocolSection.conditionsModule.conditions)
  • KRAS G12F (protocolSection.conditionsModule.conditions)
  • KRAS G12R (protocolSection.conditionsModule.conditions)
  • KRAS G13D (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.